Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Medtronic
Express Scripts
Dow
McKesson
Merck

Last Updated: November 11, 2019

DrugPatentWatch Database Preview

Litigation Details for Baker v. MBNA Corp. (D. Del. 2005)

See Plans and Pricing

« Back to Dashboard

Baker v. MBNA Corp. (D. Del. 2005)

Docket   Start Trial Date Filed 2005-05-05
Court District Court, D. Delaware Date Terminated 2009-10-06
Cause 15:78m(a) Securities Exchange Act Assigned To Gregory Moneta Sleet
Jury Demand Plaintiff Referred To
Parties ACTIVEST INVESTMENTGESELLSCHAFT MBH; ARCA S G R SPA; BRUCE L. HAMMONDS; CHARLES C. KRULAK; CITY OF DEERFIELD BEACH NON-UNIFORM EMPLOYEES RETIREMENT PLAN; JAMES M. BAKER; JOHN R. COCHRAN, III; JOHN W. SCHEFLEN; KENNETH A. VECCHIONE; LANCE L. WEAVER; MBNA CORP.; MICHAEL G. RHODES; RALPH SIANNI; RICHARD K. STRUTHERS; SOCIETE GENERALE SECURITIES SERVICES KAPITALANLAGEGESELLSCHAFT MBH
Patents 4,721,723
Attorneys Ann Ritter; Brian D. Long; Caroline Bernard; Gregg S. Levin; Jeffrey S. Goddess; John McConnell; Marc H. Snyder; Martha H. Rhodes; Meghan S.B. Oliver; Michele Sherretta Budicak; Ralph Nicholas Sianni; Richard H. Morse; Seth D. Rigrodsky; William E. Applegate , IV; William Narwold
Firms Rigrodsky & Long, P.A.; Rosen Moss Snyder & Bleefeld; Rosenthal, Monhait & Goddess, P.A.; Stewarts Law US LLP, I.M. Pei Building; Young, Conaway, Stargatt & Taylor LLP
Link to Docket External link to docket
Small Molecule Drugs cited in Baker v. MBNA Corp.
The small molecule drugs covered by the patent cited in this case are   Start Trial and   Start Trial .

Details for Baker v. MBNA Corp. (D. Del. 2005)

Date Filed Document No. Description Snippet Link To Document
2008-08-01 130 Exhibit Tabs 1-3 to Compendium of Unreported Opinions Cited in Plaintiffs' Defendants infringed Patent No. 4,721,723 (“the '723 Patent”), which the United States Patent and Trademark… named inventors in the ‘723 patent, Defendants argue the '723 patent is invalid under 35 U.S.'…validity of the patent Bristol~Myers does not say 'notiication letters to patent*holders must assert…#39;723 patent SmithKline argues topics 15~17 are irrelevant to the interpretation of the patent claim …collecn'vely “SmithKline”) idled a one»count patent infringement complaint against Defendants Apotex External link to document
>Date Filed >Document No. >Description >Snippet >Link To Document

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Johnson and Johnson
Colorcon
Express Scripts
Mallinckrodt
Baxter

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.